curiousaboutbb

Love the story! Can’t wait for the next chapter!

He will do much better than Trump. Trump has done the exact same mental mistakes if you want to call it that As Biden has. Maybe even worse! Mental capacity is gonna be the selling point for the right though. It ain’t gonna work! Too many people are sick of Trump and his antics. At least Biden will have reasonable advisers around him to help him make decisions instead of thinking he is God and making all of them on his own!

Pics on bbrt look pretty real

I wouldn’t switch without consulting your Doc. Best way to be sure you take it is to get a daily pill box. Take it each morning as you brush your teeth. If you aren’t sure if you have taken it you can check your pill box and see.

Such a hot story!

Love this story. Hope there is more to come.

Excited about the next chapter!

Excited about the next chapter!

Excited about the next chapter!

Excited about the next chapter!

Syphillis, chlamydia and gonorrhea are pretty easily cured with antibiotics. Just make sure you are tested for them every 3-6 months. Syphillis can progress to a serious illness if left untreated. I get tested every time I go in for my PrEP check up. I have not caught any of them, but I am not an extreme barebacker. I only bb, but probably less than 20-30 guys a year. The things I would worry about most are HSV2 (herpes) and HPV. These are not curable. HEPC is also another worry although it is now curable most of the time. I hope this helps.

Famous Last Words https://breeding.zone/topic/13365-famous-last-words/

The coccyx is what I had also. I just couldn't remember what he called it. Inflamed coccyx I believe is what it was called.

I had something Like this. When I would cum my pelvis anal regions would feel cramped and hurt. Went to a chiropractor and he called it something. One adjustment and the pain was gone.

My cost is $40 a month with insurance. I have the copay card that covers that, so my out of pocket is 0.

Bottom line is It all comes down to money for an insurance company. Don't forget insurance companies negotiate the price of the drugs, they pay much less than the retail price. It is more cost beneficial to prevent HIV than to treat. I think it is something like 12,000 per year to prevent and almost 30,000 to treat. Add to this the fact you are dealing with high risk individuals (not if but when) it makes it even more beneficial to prevent. It's really a no brainier. Assurant has already reversed its decision not to cover and contacted those that received this letter.

http://www.aidsmeds.com/articles/PrEP_drug_resistance_1667_26703.shtml This article appears to be talking about a similar thing. Two subjects converted on prep study. The strain they had was resistant to the emtricitabine. They seemed to think they developed resistance. I wonder if ther were just like the guy in the post being discussed. I am on truvada and it is a little unnerving. For the first time, a study has shown that, although rare, resistance to Truvada (tenofovir/emtricitabine) can develop if someone contracts HIV while taking the drug as pre-exposure prophylaxis (PrEP). In previous studies this had only been found to occur if someone turned out to be acutely, or very newly, infected with HIV when they started taking PrEP. (An HIV test may yield a false negative if conducted during an acute infection, possibly leading someone to enter a PrEP study under the false impression that he or she does not have the virus.) Publishing their findings in the Journal of Infectious Diseases, researchers analyzed plasma samples from the 121 study participants who contracted HIV in the Partners PrEP Study. They tested the samples for HIV that had resistance mutations associated with emtricitabine or tenofovir. The study was a Phase III, randomized, double-blind, placebo-controlled trial in which the HIV-negative member of 4,747 mixed-HIV status heterosexual couples was assigned to receive Truvada or tenofovir as PrEP, or a placebo. Out of those who tested HIV positive during the study, 25 were assigned Truvada, 38 were assigned tenofovir and 58 were assigned the placebo. Drug levels in the plasma indicated that 26 participants had taken PrEP during or after acquiring the virus. Out of this group, five people had evidence of resistance mutations associated with their PrEP regimen: four of seven (57 percent) of those who took Truvada, and one of 19 (5.3 percent) who took tenofovir. The difference in resistance rates between the two groups was the result of the development of the emtricitabine-related resistance mutation M184IV. Of the five participants who had drug resistance, three were found to have been acutely infected when they started the trial, leaving two people who were HIV-negative when they enrolled. These two people are key, because their cases indicate that there is a possibility of contracting HIV while taking PrEP and then developing drug resistance, although this chance is apparently rare. The authors state that that risk of drug resistance may be higher in those who are taking PrEP around the time that they are infected and in those who, because of infrequent follow-up testing, take PrEP for an extended period after contracting the virus. Truvada as PrEP is highly effective if taken daily as prescribed, but loses efficacy if taken less frequently. U.S. Food and Drug Administration protocol recommends that people taking PrEP undergo HIV testing every three months. The participants in this study were tested monthly. The study found that resistance was more likely to develop to the emtricitabine component of Truvada, meaning that only taking tenofovir instead of Truvada, which also emtricitabine in addition to tenofovir, would lower the risk of resistance. However, the authors state that this risk must be weighed against the 49 percent increased efficacy of Truvada over tenofovir as PrEP that was found in the Partners study. In an accompanying editorial, Robert M. Grant, MD, MPH, a professor at the University of California, San Francisco, who led the iPrEx study that proved PrEP’s efficacy among men who have sex with men (MSM) in 2010, and Teri Liegler, PhD, an associate professor at UCSF, write, “Fear of drug resistance is now raised as we consider rolling out PrEP.” However, they add, “Fomenting fear of drug resistance is also misguided if it distracts us from fear of HIV itself, by far the greater threat to human health.”

Did your doc not do a full STI panel before putting you on PrEP?

Get the copay card it will cover copay up to $200. My copay is $40 but with the card it's $0

Giving this thread a bump. I am three days in on PreP and no side effects noticed thus far. Anyone had any side effects? If so what type and when did they occur? Thanks.

Update Finally got my prescription for PreP today after 4 months of trying to get on it. With the copayment card I paid $0. Was actually glad my insurance didn't hassle me about it. Starting it in the morning hopefully the side effects will be minimal.

Here is a doctor that prescribes prep. He is in Richmond which I know is a couple hours away. I would bet his office could direct you to someone in va beach who prescribes it. michael edmond at vcu- he's part of the internal medicine dept. :-) http://www.people.vcu.edu/~medmond/patient_care.html

Yes and yes. Small world! You know any others.

Thanks RT. One other thing I find shocking is how long the process takes. We are not scheduled to meet back until august 15th to go over results. If I decide to go on it then, I am sure I will have to get insurance approval. Most likely it will be September before I actually get to start taking it.